Literature DB >> 26622635

Glucagonoma syndrome: A case report.

Jishu Wei1, Shibo Lin1, Cong Wang2, Junli Wu1, Zhuyin Qian1, Cuncai Dai1, Kuirong Jiang1, Y I Miao1.   

Abstract

Necrolytic migratory erythema (NME), diabetes mellitus and glucagon-secreting tumors form the hallmarks of glucagonoma syndrome, and represent the major clinical manifestations of glucagonoma. NME is usually presented as the initial complaint of patients. Due to the rare incidence of glucagonoma, its diagnosis is often delayed, which leads to its progression. Here, we report a case of NME with a typical skin rash, which was misdiagnosed and treated with corticosteroids for two years. Removal of the tumor in the pancreatic body led to the rapid relief of the symptoms. The aim of the present study is to demonstrate the typical characteristics of glucagonoma syndrome to clinicians in order to improve its diagnosis and treatment.

Entities:  

Keywords:  diabetes mellitus; glucagonoma; necrolytic migratory erythema

Year:  2015        PMID: 26622635      PMCID: PMC4509032          DOI: 10.3892/ol.2015.3275

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Necrolytic migratory erythema associated with glucagonoma syndrome.

Authors:  Weimin Shi; Wanqing Liao; Xingyu Mei; Qin Xiao; Yu Zeng; Qun Zhou
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Evidence for a catabolic role of glucagon during an amino acid load.

Authors:  M R Charlton; D B Adey; K S Nair
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.

Authors:  C-H Lo; C L Ho; Y L Shih
Journal:  QJM       Date:  2013-02-06

Review 4.  Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema.

Authors:  E A Mullans; P R Cohen
Journal:  J Am Acad Dermatol       Date:  1998-05       Impact factor: 11.527

Review 5.  Glucagon and its family revisited.

Authors:  P J Lefèbvre
Journal:  Diabetes Care       Date:  1995-05       Impact factor: 19.112

6.  Metastatic glucagonoma: treatment with liver transplantation.

Authors:  Peter Radny; Thomas Kurt Eigentler; Karsten Soennichsen; Dietrich Overkamp; Hans-Rudolf Raab; Richard Viebahn; Christian Mueller-Horvart; Karl Sotlar; Gernot Rassner
Journal:  J Am Acad Dermatol       Date:  2006-02       Impact factor: 11.527

Review 7.  Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases.

Authors:  J Soga; Y Yakuwa
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

8.  The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Authors:  R A Wermers; V Fatourechi; A G Wynne; L K Kvols; R V Lloyd
Journal:  Medicine (Baltimore)       Date:  1996-03       Impact factor: 1.889

9.  Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma.

Authors:  Guido Poggi; Laura Villani; Giovanni Bernardo
Journal:  Rare Tumors       Date:  2009-07-22

10.  Population-based study of islet cell carcinoma.

Authors:  James C Yao; Milton P Eisner; Colleen Leary; Cecile Dagohoy; Alexandria Phan; Asif Rashid; Manal Hassan; Douglas B Evans
Journal:  Ann Surg Oncol       Date:  2007-09-26       Impact factor: 5.344

View more
  5 in total

1.  MANIFESTATIONS OF GLUCAGONOMA SYNDROME.

Authors:  Mauricio Alvarez; Andres Almanzar; Fabian Sanabria; Gustavo Meneses; Louis Velasquez; Luis Zarate
Journal:  AACE Clin Case Rep       Date:  2020-01-03

2.  Glucagonoma and Glucagonoma Syndrome: A Case Report with Review of Recent Advances in Management.

Authors:  Ashraf Al-Faouri; Khaled Ajarma; Samer Alghazawi; Sura Al-Rawabdeh; Adnan Zayadeen
Journal:  Case Rep Surg       Date:  2016-02-14

3.  Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.

Authors:  Xuefeng Cao; Xixiu Wang; Yanmin Lu; Baolei Zhao; Jian Shi; Qinghai Guan; Xingyuan Zhang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

4.  Diarrhea: a missed D in the 4D glucagonoma syndrome.

Authors:  Marlone Cunha-Silva; Julia Guimarães da Costa; Guilherme Amorim Souza Faria; Juliana Yumi Massuda; Maria Letícia Cintra; Larissa Bastos Eloy da Costa; Vítor Marques Assad; Elaine Cristina de Ataíde; Daniel Ferraz de Campos Mazo; Tiago Sevá-Pereira
Journal:  Autops Case Rep       Date:  2019-11-27

5.  Case of delayed diagnosis of necrolytic migratory erythema.

Authors:  Wissal Abdelli; Fatima Alaoui; Asmahen Souissi; Wiem Sassi; Ines Chelly; Slim Haouet; Mourad Mokni
Journal:  Clin Case Rep       Date:  2021-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.